-
-
Reduced renal function may define a subset of patients most likely to benefit from ACE-inhibitor therapy for cardiovascular protection.
-
Although levels of various inflammatory biomarkers are significantly related to future cardiovascular risk, their incremental predictive value is modest.
-
In fiscal 2003, 10.8% of Medicare patients undergoing cardioverter-defibrillator implantation experienced one or more early complications, associated with significant increases in LOS and costs.
-
Ablation of AVNRT in patients with AF was associated with improved outcomes compared with those with other triggers of AF.
-
Heart failure today is the focus of enormous growth of interest in research, clinical trials, and improved care. A number of factors are responsible for the increasing prominence of congestive heart failure (CHF).
-
DFT reassessment after the institution of antiarrhythmic drug therapy with amiodarone or sotalol is not routinely required.
-
What is the role of raloxifene for the treatment of osteoporosis and breast cancer prevention? Raloxifene is a selective estrogen-receptor modulator similar to tamoxifen.
-
-
Methicillin-resistant Staphylococcus aureus (MRSA) in the community was the cause of the majority of skin and soft tissue infections, and was predominantly of one strain different from MRSA of hospital origin.
